{"id":"W4406149118","doi":"10.1016/j.oooo.2024.10.096","title":"Iscalimab (CFZ533) in patients with Sjögren disease: week 24 efficacy and safety results of a randomized, placebo-controlled, phase 2b dose-ranging study","year":2025,"lang":"en","type":"article","venue":"Oral Surgery Oral Medicine Oral Pathology and Oral Radiology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dose-ranging study; Placebo; Randomized controlled trial; Phases of clinical research; Safety profile; Phase (matter); Dermatology; Internal medicine; Adverse effect; Double blind; Clinical trial; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001999562,0.001670408,0.003303068,0.0007898475,0.0005459959,0.001200574,0.0009659294,0.002493228,0.003999],"category_scores_gemma":[0.00142629,0.0006385892,0.001723757,0.0005473833,0.001204875,0.00120258,0.0002870481,0.002995917,0.0008025346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006734619,"about_ca_system_score_gemma":0.0008329183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006459435,"about_ca_topic_score_gemma":0.001164054,"domain_scores_codex":[0.9993254,0.0002833568,0.00004532363,0.0001200211,0.00008109238,0.0001448232],"domain_scores_gemma":[0.9990314,0.0002598739,0.0002696312,0.00007546695,0.00007924398,0.0002844553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.936412,0.01137551,0.001303572,0.0007081138,0.0009517076,0.00007893804,0.00006976829,0.0006062283,0.01006474,0.00007264136,0.0009603572,0.03739648],"study_design_scores_gemma":[0.8510346,0.1405873,0.005555229,0.00004422382,0.0004541208,0.00008002799,0.00003163332,0.0004609678,0.001074202,0.00009314661,0.0005586553,0.00002597677],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915612,0.004649115,0.0003898703,0.0003730019,0.0001888955,0.001024466,0.0004849133,0.0001316952,0.001196815],"genre_scores_gemma":[0.9923871,0.002185348,0.0008193398,0.0008532287,0.0003466222,0.0009552528,0.0006976682,0.00002852176,0.001726987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003999,"threshold_uncertainty_score":0.01337796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01631337186782924,"score_gpt":0.2865686407360584,"score_spread":0.2702552688682292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}